Researchers use environmental, nutritional, and lifestyle data to determine whether Cilento, Italy, shares trait characteristics with ‘Longevity Blue Zones’.
FDA accept NextPoint Therapeutics IND for HHLA2 targeting mAb – Pharmaceutical Technology
Share this article Nextpoint’s drug candidate is being investigated to treat patients with solid tumours that express tumour antigen HHLA2, such as some breast and